Literature DB >> 9738804

Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group.

J E Terrell1, S G Fisher, G T Wolf.   

Abstract

OBJECTIVE: To assess long-term quality of life in surviving patients with advanced laryngeal cancer.
DESIGN: A follow-up long-term quality-of-life survey of patients randomized to the Veterans Affairs Laryngeal Cancer Study No. 268 on induction chemotherapy and radiation (CT + RT) vs surgery and RT. SETTING AND PATIENTS: Forty-six (71%) of the 65 surviving patients with prior stage III or IV laryngeal cancer who could be contacted completed the survey: 25 from the surgery and RT group and 21 from the CT + RT group. Baseline demographic and clinical characteristics among survey respondents were similar, except that those in the CT + RT group were significantly older (mean, 61.2 years) than those in the surgery and RT group (mean, 55.7 years; P<.05). INTERVENTIONS AND MAIN OUTCOME MEASURES: Patients completed the University of Michigan Head and Neck Quality of Life (HNQOL) instrument, the Medical Outcomes Studies Short-Form 36 (SF-36) general health survey, the Beck Depression Inventory as well as smoking and alcohol consumption surveys.
RESULTS: Patients randomized to the CT + RT group had significantly better (P<.05) quality-of-life scores on the SF-36 mental health domain (76.0) than the surgery and RT group (63.0), and also had better HNQOL pain scores (81.3 vs 64.3). Compared with patients who underwent laryngectomy, patients with intact larynges (CT + RT with larynx) had significantly less bodily pain (88.5 vs 56.5), better scores on the SF-36 mental health (79.8 vs 64.7), and better HNQOL emotion (89.7 vs 79.4) scores. More patients in the surgery and RT group (28%) were depressed than in the CT + RT group (15%).
CONCLUSION: Better quality-of-life scores in the CT + RT groups appear to be related to more freedom from pain, better emotional well-being, and lower levels of depression than to preservation of speech function.

Entities:  

Mesh:

Year:  1998        PMID: 9738804     DOI: 10.1001/archotol.124.9.964

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  35 in total

1.  Laryngeal preservation: what is the best treatment strategy?

Authors:  Ehab Y Hanna
Journal:  Curr Oncol Rep       Date:  2004-05       Impact factor: 5.075

2.  [Multimodal laryngeal preservation: current data-based opinion].

Authors:  A Dietz; A Boehm; G Wichmann; D Niederwieser; S Dietzsch; M Fuchs
Journal:  HNO       Date:  2012-01       Impact factor: 1.284

3.  Patient-reported financial toxicity and adverse medical consequences in head and neck cancer.

Authors:  Whitney H Beeler; Emily L Bellile; Keith A Casper; Elizabeth Jaworski; Nicholas J Burger; Kelly M Malloy; Matthew E Spector; Andrew G Shuman; Andrew Rosko; Chaz L Stucken; Steven B Chinn; Aleksandar F Dragovic; Christina H Chapman; Dawn Owen; Shruti Jolly; Carol R Bradford; Mark E P Prince; Francis P Worden; Reshma Jagsi; Michelle L Mierzwa; Paul L Swiecicki
Journal:  Oral Oncol       Date:  2019-12-23       Impact factor: 5.337

4.  Changing the perspective: current trends in the assessment of functional outcome in patients with head and neck cancer.

Authors:  Uta Tschiesner
Journal:  Curr Oncol Rep       Date:  2011-04       Impact factor: 5.075

5.  Neighborhood deprivation and clinical outcomes among head and neck cancer patients.

Authors:  Lorraine R Reitzel; Nga Nguyen; Mark E Zafereo; Guojun Li; Qingyi Wei; Erich M Sturgis
Journal:  Health Place       Date:  2012-03-14       Impact factor: 4.078

6.  [Quality of life for patients after laryngectomy and surgical voice rehabilitation. Experience with the Provox prosthesis].

Authors:  M Tisch; K J Lorenz; E Störrle; H Maier
Journal:  HNO       Date:  2003-03-27       Impact factor: 1.284

7.  [Swallowing disorders after partial laryngectomy. Prevalence and predictors].

Authors:  A Meyer; A Dietz; D Wollbrück; J Oeken; H Danker; E F Meister; A Sandner; W Völkel; E Brähler; S Singer
Journal:  HNO       Date:  2012-10       Impact factor: 1.284

Review 8.  Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review.

Authors:  Lisette van der Molen; Maya A van Rossum; Lori M Burkhead; Ludi E Smeele; Frans J M Hilgers
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-09-30       Impact factor: 2.503

9.  Individualized outcome prognostication for patients with laryngeal cancer.

Authors:  Connor W Hoban; Lauren J Beesley; Emily L Bellile; Yilun Sun; Matthew E Spector; Gregory T Wolf; Jeremy M G Taylor; Andrew G Shuman
Journal:  Cancer       Date:  2017-11-07       Impact factor: 6.860

Review 10.  Organ preservation surgery for laryngeal cancer.

Authors:  Sharad Chawla; Andrew Simon Carney
Journal:  Head Neck Oncol       Date:  2009-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.